Gynecomastia: pathophysiology, evaluation, and management.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 19880691.
- Also identified by DOI 10.1016/S0025-6196(11)60671-X and PMC identifier 2770912.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Gynecomastia, defined as benign proliferation of male breast glandular tissue, is usually caused by increased estrogen activity, decreased testosterone activity, or the use of numerous medications. Although a fairly common presentation in the primary care setting and mostly of benign etiology, it can cause patients considerable anxiety. The initial step is to rule out pseudogynecomastia by careful history taking and physical examination. A stepwise approach that includes imaging and laboratory testing to exclude neoplasms and endocrinopathies may facilitate cost-effective diagnosis. If results of all studies are normal, idiopathic gynecomastia is diagnosed. The evidence in this area is mainly of observational nature and lower quality.
Medical subject headings
- Antineoplastic Agents, Hormonal
- Breast Neoplasms, Male
- Gynecomastia